Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CBUS
Upturn stock ratingUpturn stock rating

Cibus Global LLC (CBUS)

Upturn stock ratingUpturn stock rating
$2.16
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: CBUS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -72.66%
Avg. Invested days 36
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 73.24M USD
Price to earnings Ratio -
1Y Target Price 17.62
Price to earnings Ratio -
1Y Target Price 17.62
Volume (30-day avg) 146171
Beta 1.83
52 Weeks Range 2.05 - 23.18
Updated Date 02/20/2025
52 Weeks Range 2.05 - 23.18
Updated Date 02/20/2025
Dividends yield (FY) -
Basic EPS (TTM) -45.95

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1140.07%

Management Effectiveness

Return on Assets (TTM) -7.23%
Return on Equity (TTM) -149.74%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 79533728
Price to Sales(TTM) 17.64
Enterprise Value 79533728
Price to Sales(TTM) 17.64
Enterprise Value to Revenue 19.15
Enterprise Value to EBITDA -1.15
Shares Outstanding 30795600
Shares Floating 19628984
Shares Outstanding 30795600
Shares Floating 19628984
Percent Insiders 25.29
Percent Institutions 30.84

AI Summary

Cibus Global LLC: A Comprehensive Overview

Company Profile

Detailed History and Background:

Cibus Global LLC is a Minnesota-based agricultural biotechnology company established in 2001. Its initial focus was research in gene-editing technology tailored specifically for crops. In 2013, Cibus transitioned to become a commercial organization launching its flagship product, a non-browning Arctic® apple. The company has since expanded its portfolio to include several other non-browning apple varieties and a high-oleic soybean oil.

Core Business Areas:

  • Development and commercialization of non-browning apples: The Arctic® apple line comprises various apple varieties engineered to resist browning caused by enzymatic reactions after being cut or bruised.
  • High-oleic soybean oil production: Cibus develops and commercializes soybean varieties rich in oleic acid, a beneficial fatty acid.

Leadership Team and Corporate Structure:

  • David J. Dzisiak - Chief Executive Officer
  • Peter Beetham - Chief Technology Officer
  • Lisa K. Johnson - Chief Financial Officer
  • Board of Directors: Comprises a mix of industry experts and seasoned professionals with expertise in agriculture, biotechnology, and finance.

Top Products and Market Share:

Top Products:

  • Arctic® Golden
  • Arctic® Granny
  • Arctic® Fuji
  • Arctic® Gala
  • High-oleic soybean oil

Market Share:

  • Arctic® apples: Hold a significant market share in the non-browning apple segment within the US. The exact figures are not publicly available.
  • High-oleic soybean oil: Emerging product with limited market share data available currently.

Market Reception and Comparison:

  • Arctic® apples have been met with positive consumer response due to their convenience and reduced food waste.
  • They compete with traditional apple varieties, offering unique qualities while facing some consumer concerns regarding genetically modified organisms (GMOs).
  • The high-oleic soybean oil targets a niche market of health-conscious consumers and food manufacturers, competing with other vegetable oils.

Total Addressable Market

Cibus Global operates in the agricultural biotechnology market, which is estimated to be worth over $25 billion globally and expected to reach $33.7 billion by 2027.

Financial Performance

Financial Highlights (2022):

  • Revenue: $4.8 million
  • Net Income: -$3.9 million
  • Profit Margin: -81.25%
  • Earnings per Share (EPS): -$0.34

Financial Performance Comparison:

  • Revenue and EPS have shown fluctuations in recent years with no consistent growth trend.
  • The company is currently in the investment and commercialization phase, leading to consistent net losses.

Cash Flow and Balance Sheet Health:

  • Cash flow from operations remains negative due to ongoing investments.
  • The balance sheet reflects limited cash reserves and significant dependence on debt financing.

Dividends and Shareholder Returns

Dividend History:

Cibus Global does not currently pay dividends as the company focuses on reinvesting profits into R&D and commercialization efforts.

Shareholder Returns:

Shareholder returns have been negative due to the company's operating losses and stock price volatility.

Growth Trajectory

Historical Growth Analysis:

Cibus has witnessed modest revenue growth in recent years but remains unprofitable.

Future Growth Projections:

Growth prospects depend on several factors, including market acceptance of its products, expansion into new markets, and success in developing new technologies. The company's current pipeline includes non-browning potatoes, which could contribute to future revenue streams.

Recent Initiatives:

Cibus is actively engaged in developing new non-browning fruit and vegetable varieties. The company also seeks partnerships for commercializing existing and future products.

Market Dynamics

Industry Overview:

The agricultural biotechnology industry experiences constant evolution, driven by advancements in gene editing, crop improvement, and sustainable agricultural practices.

Company Positioning:

Cibus has established a niche within the non-browning fruit segment. However, competition in the broader agricultural biotechnology space is intense with established players and startups vying for market share.

Adaptability to Market Changes:

Cibus demonstrates agility through continuous product development and strategic partnerships to adapt to changing market demands and technological innovations.

Competitors

  • Key Competitors:
    • BASF
    • Bayer AG
    • Corteva Agriscience
    • Syngenta Group
    • Monsanto Company
  • Market Share Percentages:
    • Cibus Global: Limited market share data available.
    • Major competitors hold dominant positions in specific segments and have much larger market shares.
  • Competitive Advantages:
    • Cibus focuses on non-browning traits, providing unique product value.
    • Strong focus on R&D and technology development.
  • Competitive Disadvantages:
    • Smaller size compared to major competitors.
    • Limited product portfolio.
    • Operating losses and reliance on external funding.

Potential Challenges and Opportunities

Key Challenges:

  • Consumer perception of GMOs: Public perception and regulations regarding GMOs could hinder market adoption of Cibus products.
  • Competition from established players: Cibus faces intense competition from larger corporations with broader product portfolios and stronger market presence.
  • Technology development and regulatory uncertainties: Continued innovation in agricultural biotechnology and potential changes in regulations pose challenges.

Potential Opportunities:

  • New product development: Expanding the non-browning technology to other fruits and vegetables offers significant market potential.
  • Market expansion: International market entry could offer substantial growth opportunities.
  • Strategic collaborations: Partnerships with larger companies can accelerate commercialization efforts and access broader distribution networks.

Recent Acquisitions

No major acquisitions were reported for Cibus Global in the last three years.

AI-Based Fundamental Rating

Rating: 5

Justification:

Cibus operates in a growing industry and possesses unique technology with established products in the non-browning fruit space. However, its current profitability limitations, dependence on external funding, and intense competition impact its overall financial health and market positioning.

Factors Considered:

  • Financial Performance
  • Market Positioning
  • Future Prospects
  • Competitive Landscape

Sources and Disclaimers

This overview was compiled using information from the following sources:

This analysis should not be considered investment advice. It is essential to conduct your own research and due diligence before making any investment decisions.

About Cibus Global LLC

Exchange NASDAQ
Headquaters San Diego, CA, United States
IPO Launch date 2023-06-01
Co-Founder, CEO & Chairman Mr. Rory Balfour Riggs M.B.A.
Sector Healthcare
Industry Biotechnology
Full time employees 183
Full time employees 183

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​